I'm sure you all make use of PubMed (and probably Google Scholar) to try and keep up with the literature in your field. Wouldn't it be nice if there was a way to have automate the process? And have not only the results of your searches but also things like journal tables of content delivered in a single, user-friendly package?

There is.

The University of Kentucky Markey Cancer Center celebrated 10 years of Markey Research Day this past Tuesday. Sponsored by the Markey Cancer Foundation, Markey Research Day is an opportunity for researchers who study any aspect of cancer to share their work and receive feedback from colleagues across campus. Markey’s reach extends across 10 of UK’s 16 colleges, and the work on display at Research Day showcases the wide variety and diversity of perspectives that fall under the Markey umbrella. 

By Nancy Galvagni

The National Institute on Drug Abuse ranks Kentucky among the top 10 states with the highest opioid-related overdose deaths, and Kentucky’s hospitals are on the frontline in the fight to help the state recover. To assist the state’s hospitals in this battle, the Kentucky Hospital Association (KHA) is partnering with the Cabinet for Health and Family Services as part of the Kentucky Opioid Response Effort (KORE) to launch the Kentucky Statewide Opioid Stewardship (KY SOS) program.

This month's book is "Work Simply: Embracing the Power of Your Personal Productivity Style" by Carson Tate

Find it here!

This week, the University of Kentucky Board of Trustees approved 16 University Research Professorships for the 2019-20 academic year.

The purpose of the University Research Professorship program is to recognize and publicize research accomplishments of scholars across the full range of disciplines at UK. The award amount is $10,000 for one year, to be used to further the research, scholarship and creative endeavors of the awardee.  

In the past, using the terms "Alzheimer’s disease" and "dementia" interchangeably was a generally accepted practice. Now there is rising appreciation that a variety of diseases and disease processes contribute to dementia.

According to Nina Silverberg, Ph.D., director of the Alzheimer's Disease Centers Program at National Institute on Aging (NIA), part of NIH, in the past many of the people who enrolled in clinical trials for Alzheimer's drugs likely did not have amyloid — the sticky substance that gums up neurons and interferes with thinking — in their brains.